Archive

Preliminary Results from Synergy Trial Released

May 14, 2015

The long-awaited preliminary results from the K-PAX Synergy Trial are out. While both the patient group and control groups showed improvements, the difference between the two was not statistically significant. The Synergy Trial was designed to produce an FDA-approvable treatment for ME/CFS. Read More…

Being “Patient-Centric”

December 8, 2014

Patients are central to a solution for ME/CFS. We have designed our SolveCFS BioBank™ to collect and manage data so that the individual is the central organizing principle. LEARN MORE…

Research Digest – August 2014: More Results from the SolveCFS BioBank

August 22, 2014

More results from the work being done through the SolveCFS BioBank: We are pleased to report the publication of the initial BioBank study on XMRV and the publication of the first study of epigenetics in ME/CFS. Both used the clinical information and samples from the SolveCFS BioBank that were collected in 2010. READ MORE…

Same Mission | New Name

May 30, 2014

As of Friday, May 30th, The CFIDS Association of America will have a new name – Solve ME/CFS Initiative (SMCI). While our name is changing, our mission steadfastly remains the same: We will make ME/CFS understood, diagnosable and treatable…

The Physical Basis of CFS

September 6, 2013

By John DeLuca, PhD UMDNJ-New Jersey Medical School Studies assessing structural and functional neuroimaging, autonomic activity and neuroendocrine abnormalities all point to neuro-pathology in chronic fatigue syndrome (CFS) patients. While the nature and the extent of neuropathologic involvement in CFS is still unclear, neurocognitive studies […]